Lee Jennifer Kayden (CIK 1801372) reported 20 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-03). Recent activity: Buy RYTM (22,612 shares), Sell RYTM (9,237 shares), Buy RYTM (5,500 shares), Sell RYTM (2,035 shares), Sell RYTM (600 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-03 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | EVP, Head of North America | Buy | 22,612 | $0 |
| 2026-02-03 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | EVP, Head of North America | Sell | 9,237 | $1.0M |
| 2025-02-19 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | EVP, Head of North America | Buy | 5,500 | $0 |
| 2025-02-19 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | EVP, Head of North America | Sell | 2,035 | $116,443 |
| 2025-02-14 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | EVP, Head of North America | Sell | 600 | $33,834 |
| 2025-02-14 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | EVP, Head of North America | Sell | 10 | $564 |
| 2025-02-14 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | EVP, Head of North America | Sell | 1,205 | $67,950 |
| 2025-02-14 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | EVP, Head of North America | Sell | 1,205 | $69,890 |
| 2025-02-11 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | EVP, Head of North America | Buy | 3,437 | $0 |
| 2025-02-11 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | EVP, Head of North America | Buy | 4,189 | $28,485 |
| 2025-02-11 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | EVP, Head of North America | Sell | 1,894 | $110,591 |
| 2025-02-11 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | EVP, Head of North America | Sell | 2,295 | $136,185 |
| 2025-02-11 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | EVP, Head of North America | Buy | 2,031 | $0 |
| 2025-02-11 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | EVP, Head of North America | Sell | 1,023 | $58,833 |
| 2025-02-11 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | EVP, Head of North America | Sell | 4 | $230 |
| 2025-02-07 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | EVP, Head of North America | Sell | 1,733 | $104,119 |
| 2025-02-07 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | EVP, Head of North America | Sell | 1,133 | $69,124 |
| 2025-02-07 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | EVP, Head of North America | Sell | 200 | $12,390 |
| 2025-02-04 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | EVP, Head of North America | Buy | 4,513 | $0 |
| 2025-02-04 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | EVP, Head of North America | Sell | 1,447 | $85,995 |
Source: SEC Form 4 filings · as of 2026-02-03